The peptide community that actually knows.
Real protocols. Real results. Backed by science.
The Basics
You're already running on these.
A peptide is a short chain of amino acids — the same building blocks that make up every protein in your body. The difference between a peptide and a protein is just length. Under about 50 amino acids, it's a peptide. More than that, it's a protein.
Your body produces thousands of them naturally. Right now, without any intervention, peptides are telling your pituitary gland when to release growth hormone, signaling your immune system to ramp up or stand down, instructing your gut to regulate appetite, and coordinating the repair of damaged tissue.
What changed recently isn't the science. What changed is that researchers developed the tools to synthesize specific peptides in a lab, study what they do in isolation, and use them therapeutically — to reinforce signals your body is already trying to send.
What makes them different from conventional drugs?
Targeted by design
Peptides mimic signals your body already recognizes. They work on specific receptors, not broad systems — fewer systemic side effects than conventional drugs.
Familiar to your biology
Your immune system doesn't treat a therapeutic peptide like a foreign invader. It recognizes the structure — fundamentally different from synthetic small-molecule drugs.
In and out quickly
Most peptides metabolize within hours. They don't accumulate. They deliver their signal and leave — a meaningful safety characteristic many conventional pharmaceuticals can't claim.
The Mechanism
Your cells are waiting for instructions. Peptides deliver them.
Step 1 of 4: Individual amino acids
Your body builds everything from 20 types of amino acids — tiny molecules, each with a specific shape and electrical charge. They're the alphabet your biology writes in.
Featured peptides
Most popular and well-researched compounds
BPC-157
Body Protection Compound-157 (Gastric Pentadecapeptide)
BPC-157 Arginate is a salt form of BPC-157 created by combining BPC-157 with arginine to produce a more stable compound that is orally bioavailable and does not require refrigeration. While standard BPC-157 acetate salt degrades relatively quickly and is typically administered by injection the arginate form has improved stability and demonstrated efficacy via oral administration in research studies. This development has significant practical implications making BPC-157's benefits accessible without injection for users who prefer oral supplementation.
CJC-1295
CJC-1295 with Drug Affinity Complex (DAC)
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates pituitary growth hormone release. The DAC modification extends its half-life to approximately 6-8 days, allowing for less frequent dosing. It is widely used for anti-aging, fat loss, sleep improvement, and overall growth hormone optimization.
GHK-Cu
Glycyl-L-Histidyl-L-Lysine Copper Complex
GHK (Glycyl-L-Histidyl-L-Lysine) is a naturally occurring copper-binding tripeptide found in human plasma saliva and urine that declines significantly with age — from 200 ng/mL at age 20 to 80 ng/mL at age 60. It is one of the most extensively studied peptides for skin rejuvenation wound healing hair growth and anti-aging applications with over 50 years of research. GHK-Cu promotes collagen and elastin synthesis resets gene expression toward more youthful patterns and has systemic effects beyond skin. It is widely used in premium cosmeceuticals and increasingly studied for systemic injectable applications.
A century of peptide science
Key milestones from lab bench to mainstream medicine
A dying 14-year-old diabetic receives the first injection and recovers. The age of therapeutic peptides begins.
Vincent du Vigneaud synthesizes oxytocin. Proof we can build these molecules, not just extract them.
Semaglutide produces 14.9% average weight loss — numbers no drug had ever reached. Millions hear "peptide" for the first time.
The SELECT trial shows semaglutide reduces major cardiovascular events by 20% — no longer just a weight drug.
No needle. No weekly injection. A pill. The access barrier that had nothing to do with science falls.
Triple agonists, liver-targeted therapies, combination amylin. The next five years are already in Phase 3.
Join the conversation
Real people sharing real protocols, results, and questions in Pep Talk — plus curated video content from Pep Watch.
Latest from Pep Watch
VideoJim Lavalle
The anti-inflammatory peptide that most people have never heard of!
Dr. William Seeds
The Role Of Peptides In Regnerative Medicine
Jim Lavalle
What is PT-141 and how does it work for low libido?
